Actively Recruiting
A Registered Cohort Study on SMA
Led by Wan-Jin Chen · Updated on 2019-09-23
2000
Participants Needed
1
Research Sites
1591 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Spinal muscular atrophy (SMA) is an autosomal recessive disease that causes progressive muscle wasting and weakness due to loss of motor neurons in the spinal cord. This is a registered cohort of spinal muscular atrophy (SMA) type I，II and III in China. This study will provide further insights into the clinical course of SMA including overall survival, demographic characteristics, motor function, respiratory support, feeding and nutritional support, growth and development. The correlation of genotype and phenotype will be conducted.
CONDITIONS
Official Title
A Registered Cohort Study on SMA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with SMA types I, II and III
- Asymptomatic SMA carriers
- Relatives of SMA patients or carriers
- Unrelated healthy controls
- Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process
You will not qualify if you...
- Participants are unable to comply with trial procedures and visit schedule
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology, First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China, 350005
Actively Recruiting
Research Team
Y
Yi Lin, PhD
CONTACT
W
Wan-Jian Chen, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here